January 21, 2016
The Daily Startup: Abingworth Raises $105M Fund for Drug Co-Development
Malwarebytes Corp. has grabbed $50 million in Series B funding to help users disinfect their devices after malicious threats penetrate traditional antivirus software. The funding, led by Fidelity Management & Research Co., brings Malwarebytes’ total funding to date to $80 million.
Read MoreSelect your language